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In Studies conducted on patients with surgically resected stomachs, the synchronous multiplicity of gastric cancer is well known, and its frequency has been reported to range from 4.8% to 20.9% at several institutions [4] [5] [6] [7] [8] [9] [10] . In addition, the incidence of new metachronous gastric cancer (MGC) in the remnant stomach after surgery for gastric cancer ranges from 1.8% to 2.4% [11, 12] . Consequently, the remnant stomach is at high risk for the development of MGC.
Although ER contributes to preserving most of the stomach, the risk of MGC developing at other sites in the stomach in the post-ER patient has become a major problem. There have been only a few reports regarding the incidence of MGC after ER. At present, we perform annual endoscopic surveillance for post-ER patients, but the proper interval of examination after ER is still not known.
Patients and methods

Patients
The aim of this study was to investigate the clinicopathological features and incidence of MGC after ER and to assess our annual endoscopic surveillance program following ER. A total of 1129 EGCs in 973 patients were treated by ER from 1987 through 2002 at our institution. Of these patients, 633 (575 with a single lesion and 58 with synchronous multiple lesions) were evaluated in this study. We excluded 158 patients who underwent additional surgery due to noncurative ERs, 180 patients whose surveillance periods were less than 1 year, 1 patient with hereditary nonpolyposis colorectal
Introduction
Recent advances in endoscopic examinations have made it possible to detect early gastric cancer (EGC). Due to the resultant increase in the number of EGCs, cancer (HNPCC), and 1 patient with gastric tube cancer. We reviewed the clinical records, including endoscopic and histological reports, for all these patients. The average follow-up period after ER for the 633 study patients was 4.4 ± 2.8 years (range, 1.0-13.9 years), the average age of the subjects was 66.5 ± 9.0 years (range, 35-93 years) and the male-to-female ratio was 4 : 1 (510 men and 123 women).
Methods
ER and its evaluation
At the beginning of this series of consecutive ERs, most of ERs were performed by the so-called "strip biopsy method," a relatively simple technique described previously [13] . Since 1997, however, a new ER procedure using an insulation-tipped diathermic knife [14] has been used in most patients at our institution. In this study, we evaluated patients with EGC consistent with the pre-ER indications shown in Table 1 [14] [15] [16] . "Curative resections" were evaluated using the expanded histological criteria shown in Table 2 [15, 16] . The location of the tumors was defined as being in the upper, middle, or lower third of the stomach, based on the Japanese classification of gastric carcinoma [17] . The macroscopic types of EGCs were classified according to the Japanese Society for Gastroenterology Endoscopic Criteria, as type 0-I (protruded) or type 0-IIa (superficial elevated), which were both grouped together in our study as "elevated"; or as type 0-IIb (flat), type 0-IIc (superficial depressed), or type 0-IIa+IIc (elevated with central depression), which were all grouped together as "depressed" [18, 19] .
In view of the high risk of metastasis to lymph nodes or at distant sites, surgical intervention is strongly recommended for lesions with deep submucosal invasion, vessel involvement, or both. For patients who had undergone curative ER, we adopted an annual endoscopic surveillance program.
Definition of multiple EGCs
Although there is no consensus regarding the distinction between actual MGC and "missed" synchronous gastric cancer, we defined a second cancer found within 1 year after ER as "synchronous" and a second cancer found after more than 1 year as "metachronous." The diagnosis of multiple EGCs was defined according to the criteria of Moertel et al. [4] .
Statistics
The follow-up period was measured from the date of the initial ER to the date of MGC diagnosis or the date of the last endoscopic examination. The factors affecting metachronous lesions were analyzed using the Kaplan-Meier method, and a log-rank test was conducted for age, sex, and multiple synchronous lesions found at the initial ER. A P value of 0.05 was considered statistically significant.
Aim of this study
Focusing our attention on the incidence of metachronous lesions, we reviewed a large series of consecutive ERs performed at our institution. Based on data concerning the incidence, clinicopathological features, and outcomes of MGCs, we investigated the validity of our annual endoscopic surveillance program for post-ER patients.
Results
Incidence
The overall incidence for first MGCs was 8.2% (52 out of 633 patients). The male-to-female patient ratio was approximately 8 : 1 (46 men and 6 women) and the average age at the time of the initial ER was 66.5 ± 9.0 years. The average interval between the discovery of MGC and the initial ER was 3.1 ± 1.7 years, with the longest interval after the initial ER being 8.6 years ( Fig. 1) . Fourteen of the 52 MGCs were followed up as adenomas or suspicion of carcinomas. Including and excluding these 14 lesions, the cumulative 3-year incidence of the first MGC was 5.9% and 4.0%, respectively (Fig. 2) . In terms of our statistical analysis of total MGCs, neither synchronous multiplicity of gastric cancer at the initial ER, sex, nor age significantly affected MGC incidence (Fig. 3A-C) . In addition, 7 of the 52 patients with MGCs had double metachronous lesions and another 6 of them had a third metachronous lesion, all of which consisted of well-or moderately differenti- ated adenocarcinoma; all were resected curatively by repeat ER. The first metachronous lesion occurred in the same location as the initial lesion in 40.4% (21/52) of the patients. In 63.5% (33/52) of the patients, both the initial and the metachronous lesions occurred in the distal two-thirds portion of the stomach. Except for two lesions that were 30 and 40 mm in size, the median size of the MGCs was 10.3 ± 5.4 mm (range, 2-20 mm), compared to 14.9 ± 7.8 mm (range, 5-30 mm) for the initial lesions. The histology of the MGCs consisted of well-or moderately differentiated adenocarcinomas.
Outcomes
All first MGCs met the indications for ER and were treated by repeat ER within 2 months of detection, with Including and excluding metachronous lesions followed as adenoma or suspicion of carcinoma, the cumulative 3-year incidence of the first MGC was 5.9% and 4.0%, respectively, and the Kaplan-Meier curve was generally straight, suggesting that MGC incidence is constant 
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pathologically curative resections being obtained in 50 patients (96.2%); the repeat ER was judged to be noncurative in 2 patients (Table 3) . With respect to the subjects of this study, there have been no tumor-related deaths, and the incidence of noncurative MGC was only 0.3% (2 out of 633 patients), with both of these patients choosing further observation rather than additional treatment.
The two patients with noncurative MGC resections
Patient 1 was a 71-year-old man. The interval between the latest endoscopic examination and discovery of the MGC was 3 years. The depth of invasion of the metachronous lesion was classified as superficial submucosa (500 µm). There was no lymphovascular involvement, but the lesion contained a poorly differentiated component in the deepest portion. The patient refused additional surgery, however, and chose continued observation instead. Patient 2 was a 76-year-old man, and the metachronous lesion was classified endoscopically as a small 0-IIc lesion. The histopathological finding of the resected specimen revealed intramucosal cancer and moderate to poorly differentiated adenocarcinoma, but the patient refused additional surgery because of his advanced age. The interval between the latest endoscopic examination and discovery of the MGC was 6 months.
Follow-up interval
Regarding the intervals between follow-up examinations, we focused on the 52 patients with metachronous lesions. The median time interval from the last examination to the actual discovery of a metachronous lesion was 1.0 ± 0.6 years (range, 0.2-3.1 years).
The percentage of patients whose interval from the last examination to the discovery of a metachronous lesion was less than 1 year was 46.2% (24/52). Of these 24 patients, 13 had received earlier follow-up examinations due to the presence of adenomas or suspicion of carcinomas, because such patients were followed more intensively. If such a lesion was definitely evaluated as being a well-differentiated adenocarcinoma, it was resected.
Earlier follow-up examinations had been performed for five other patients at their request. As for the remaining six patients, previous examinations had been performed for limited purposes, such as the checking of gastric ulcer healing and esophagus screening, but these examinations were considered to be insufficient for detecting a metachronous lesion, and when taken into account, reduced the average time interval.
Discussion
We have shown here the overall incidence and the annual incidence of MGC. In regard to the post-ER surveillance program at our institution, annual endoscopic examinations were performed for patients who had undergone curative ER. In this study, there were no patients with tumor-related death due to a MGC. For one of the two patients with noncurative metachronous lesion resection (patient 2), the interval between the last examination and discovery of the MGC was 6 months, and the depth of invasion was intramucosal. The percentage of these patients with noncurative resections was very small, at 0.3% (2 out of 633 patients). In addition, the average time interval from the last examination to the actual discovery of a metachronous lesion was approximately 1 year. Although we could adopt a more extensive endoscopic surveillance program, undifferentiated-type gastric cancer might still occur within the surveillance period and we could not prevent any such undifferentiated type MGC. Our annual endoscopic surveillance program for the early detection of metachronous lesions was considered to be both practical and effective. The ideal approach for evaluating a screening program following ER, of course, would be to observe patients prospectively.
As for predictive factors, synchronous multiplicity of the gastric cancer and the patient's age at the time of the initial ER have been reported to significantly affect the incidence of metachronous lesions [20] , but these factors did not significantly affect this study's results.
Recent progress in endoscopic examination has made it possible to detect small EGCs, and ER for EGCs has been widely accepted as a less invasive treatment. Of note, a new one-piece resection method, known as ESD, which uses several special endoscopic tools, including an insulation-tipped diathermic knife [14] , was developed with a standard single-channel gastroscope. Compared with conventional EMR procedures, ESD has several advantages: (1) larger lesions can be resected and completely removed in one piece; (2) lesions with ulcer scars can be resected; (3) it is much easier to ensure adequate resection margins by directly visualizing the actual cut line around the lesion; and (4) it is possible to resect lesions located on the lesser curvature and posterior wall, which are considered to be more difficult to resect by EMR. As a result, such onepiece resections allow for an expansion of the indications for ER.
There have been reports of cancer of the gastric remnant occurring in 1.8% to 5% of patients who have had surgical treatment for gastric cancer [11, 21] , so the remnant stomach after such treatment is at high risk for the development of MGC. Because ER can preserve more of the stomach than surgical resection, MGC recurrence at other gastric sites after ER has become a major concern, and its early detection is critical.
Frequent follow-up examinations limit a patient's quality of life, however, and contribute to an increase in overall medical expenses. For the present, annual endoscopic examinations are considered to be acceptable. In the future, appropriate surveillance systems, which include the evaluation of several risk factors for gastric carcinogenesis, such as the existence of microorganisms, a patient's dietary habits, and genetic and epigenetic events, should be investigated and established.
For instance, a recent study reported that the eradication of Helicobacter pylori after ER of EGC decreased the incidence of MGC [22] . In the field of genetic and epigenetic events, mutations of the E-cadherin and p53 genes are reported to be involved in the multicentric carcinogenesis of diffuse gastric cancer, especially hereditary diffuse gastric cancer [23, 24] . It was also reported that patients with microsatellite instability (MSI)-positive gastric cancers had a significantly higher risk of secondary cancer than patients with MSInegative cancers [25] . DNA methylation is one of the epigenetic changes which have recently emerged as important causes of carcinogenesis. In noncancerous lesions, aberrant CpG island methylation of several genes has also been reported [26] [27] [28] [29] . In an effort to distinguish patients at high risk for metachronous lesions from those at low risk, clarification of molecular alterations that are closely linked with such characteristics would be beneficial, especially after ER.
